Autologous anti-EGFRvIII CAR T cells

EGFRvIII-targeted CAR T cells · Beijing Sanbo Brain Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous anti-EGFRvIII CAR T cells, covering 2016-07-26 to 2016-07-26. Get the full timeline:

Most recent: Clinical Trial Update: Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme [Phase 1]